Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses

被引:81
|
作者
Sievers, Benjamin L. [1 ]
Chakraborty, Saborni [2 ]
Xue, Yong [3 ]
Gelbart, Terri [1 ]
Gonzalez, Joseph C. [2 ,4 ]
Cassidy, Arianna G. [5 ]
Golan, Yarden [6 ,7 ]
Prahl, Mary [8 ]
Gaw, Stephanie L. [5 ]
Arunachalam, Prabhu S. [9 ]
Blish, Catherine A. [2 ,4 ,10 ]
Boyd, Scott D. [11 ,12 ,13 ]
Davis, Mark M. [9 ,12 ,14 ]
Jagannathan, Prasanna [2 ,12 ]
Nadeau, Kari C. [13 ]
Pulendran, Bali [9 ]
Singh, Upinder [2 ,12 ]
Scheuermann, Richard H. [1 ,15 ]
Frieman, Matthew B. [16 ]
Vashee, Sanjay [3 ]
Wang, Taia T. [2 ,4 ,10 ,12 ]
Tan, Gene S. [1 ,17 ]
机构
[1] J Craig Venter Inst, La Jolla, CA 92037 USA
[2] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
[3] J Craig Venter Inst, Rockville, MD 20850 USA
[4] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA
[5] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94115 USA
[6] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94115 USA
[7] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94115 USA
[8] Univ Calif San Francisco, Dept Pediat, Div Pediat Infect Dis, San Francisco, CA 94115 USA
[9] Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA
[10] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
[11] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
[12] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA
[13] Sean N Parker Ctr Allergy & Asthma Res, Dept Med, Stanford, CA 94305 USA
[14] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA
[15] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92037 USA
[16] Univ Maryland, Ctr Pathogen Res, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA
[17] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92037 USA
关键词
D O I
10.1126/scitranslmed.abn7842
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that have mutations associated with increased transmission and antibody escape have arisen over the course of the current pandemic. Although the current vaccines have largely been effective against past variants, the number of mutations found on the Omicron (B.1.1.529) spike protein appear to diminish the protection conferred by preexisting immunity. Using vesicular stomatitis virus (VSV) pseudoparticles expressing the spike protein of several SARS-CoV-2 variants, we evaluated the magnitude and breadth of the neutralizing antibody response over time in individuals after infection and in mRNA-vaccinated individuals. We observed that boosting increases the magnitude of the antibody response to wild-type (D614), Beta, Delta, and Omicron variants; however, the Omicron variant was the most resistant to neutralization. We further observed that vaccinated healthy adults had robust and broad antibody responses, whereas responses may have been reduced in vaccinated pregnant women, underscoring the importance of learning how to maximize mRNA vaccine responses in pregnant populations. Findings from this study show substantial heterogeneity in the magnitude and breadth of responses after infection and mRNA vaccination and may support the addition of more conserved viral antigens to existing SARS-CoV-2 vaccines.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
    Edara, Venkata-Viswanadh
    Manning, Kelly E.
    Ellis, Madison
    Lai, Lilin
    Moore, Kathryn M.
    Foster, Stephanie L.
    Floyd, Katharine
    Davis-Gardner, Meredith E.
    Mantus, Grace
    Nyhoff, Lindsay E.
    Bechnak, Sarah
    Alaaeddine, Ghina
    Naji, Amal
    Samaha, Hady
    Lee, Matthew
    Bristow, Laurel
    Gagne, Matthew
    Roberts-Torres, Jesmine
    Henry, Amy R.
    Godbole, Sucheta
    Grakoui, Arash
    Saxton, Marybeth
    Piantadosi, Anne
    Waggoner, Jesse J.
    Douek, Daniel C.
    Rouphael, Nadine
    Wrammert, Jens
    Suthar, Mehul S.
    CELL REPORTS MEDICINE, 2022, 3 (02)
  • [2] Human neutralizing antibodies elicited by SARS-CoV-2 infection
    Bin Ju
    Qi Zhang
    Jiwan Ge
    Ruoke Wang
    Jing Sun
    Xiangyang Ge
    Jiazhen Yu
    Sisi Shan
    Bing Zhou
    Shuo Song
    Xian Tang
    Jinfang Yu
    Jun Lan
    Jing Yuan
    Haiyan Wang
    Juanjuan Zhao
    Shuye Zhang
    Youchun Wang
    Xuanling Shi
    Lei Liu
    Jincun Zhao
    Xinquan Wang
    Zheng Zhang
    Linqi Zhang
    Nature, 2020, 584 : 115 - 119
  • [3] Human neutralizing antibodies elicited by SARS-CoV-2 infection
    Ju, Bin
    Zhang, Qi
    Ge, Jiwan
    Wang, Ruoke
    Sun, Jing
    Ge, Xiangyang
    Yu, Jiazhen
    Shan, Sisi
    Zhou, Bing
    Song, Shuo
    Tang, Xian
    Yu, Jinfang
    Lan, Jun
    Yuan, Jing
    Wang, Haiyan
    Zhao, Juanjuan
    Zhang, Shuye
    Wang, Youchun
    Shi, Xuanling
    Liu, Lei
    Zhao, Jincun
    Wang, Xinquan
    Zhang, Zheng
    Zhang, Linqi
    NATURE, 2020, 584 (7819) : 115 - +
  • [4] mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
    Stamatatos, Leonidas
    Czartoski, Julie
    Wan, Yu-Hsin
    Homad, Leah J.
    Rubin, Vanessa
    Glantz, Hayley
    Neradilek, Moni
    Seydoux, Emilie
    Jennewein, Madeleine F.
    MacCamy, Anna J.
    Feng, Junli
    Mize, Gregory
    De Rosa, Stephen C.
    Finzi, Andres
    Lemos, Maria P.
    Cohen, Kristen W.
    Moodie, Zoe
    McElrath, M. Juliana
    McGuire, Andrew T.
    SCIENCE, 2021, 372 (6549) : 1413 - +
  • [5] Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infection
    Migueres, Marion
    Chapuy-Regaud, Sabine
    Miedouge, Marcel
    Jamme, Thibaut
    Lougarre, Catherine
    Da Silva, Isabelle
    Pucelle, Melanie
    Staes, Laetitia
    Porcheron, Marion
    Dimeglio, Chloe
    Izopet, Jacques
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [6] Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
    Chiang, Hsiao-Ling
    Liang, Kang-Hao
    Lu, Ruei-Min
    Kuo, Ting-Wen
    Lin, Yi-Ling
    Wu, Han-Chung
    JOURNAL OF BIOMEDICAL SCIENCE, 2023, 30 (01)
  • [7] Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
    Hsiao-Ling Chiang
    Kang-Hao Liang
    Ruei-Min Lu
    Ting-Wen Kuo
    Yi‑Ling Lin
    Han-Chung Wu
    Journal of Biomedical Science, 30
  • [8] A booster with SARS-CoV-2 vaccines: protection against Omicron infection
    Yuehong Hu
    Qiu Sun
    Signal Transduction and Targeted Therapy, 7
  • [9] A booster with SARS-CoV-2 vaccines: protection against Omicron infection
    Hu, Yuehong
    Sun, Qiu
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [10] Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection
    Yu, Lei
    Wang, Yajie
    Liu, Yuanchen
    Xing, Xiaomin
    Li, Chen
    Wang, Xun
    Shi, Jialu
    Ma, Wentai
    Li, Jiayan
    Chen, Yanjia
    Qiao, Rui
    Zhao, Xiaoyu
    Tian, Shilei
    Gao, Ming
    Wen, Shuhua
    Xue, Yingxue
    Qiu, Tianyi
    Yu, Hongjie
    Guan, Yongjun
    Chu, Hin
    Sun, Lei
    Wang, Pengfei
    COMMUNICATIONS BIOLOGY, 2025, 8 (01)